Navigation Links
Nature's helpers: Using microorganisms to remove TCE from water
Date:2/28/2008

In 2002, Bruce Rittmann, PhD, director of the Biodesign Institutes Center for Environmental Biotechnology, received a patent for an innovative way to use nature to lend society a hand. He invented a treatment system, called the membrane biofilm reactor (MBfR), which uses naturally occurring microorganisms to remove contaminants from water.

Now Rittmann and his research team, which includes Rosa Krajmalnik-Brown and Jinwook Chung, recently published a paper in the journal Environmental Science & Technology for a new application that removes a problematic contaminant that has made local headlines.

The chlorinated solvent trichloroethene (TCE) has been found to be an increasingly problematic contaminant in groundwater. The detection of TCE recently forced the shut down of the water supply for the Greater Phoenix area municipalities of Paradise Valley and Scottsdale.

TCE has been widely used as a cleaning agent and solvent for many military, commercial, and industrial applications. Its widespread use, along with its improper handling, storage, and disposal, has resulted in frequent detection of TCE in the groundwater. TCE has the potential to cause liver damage, malfunctions in the central nervous system and it is considered a likely human carcinogen.

As with other elements, the chlorine cycle is becoming a key concern to many environmental pollution scientists, said Krajmalnik-Brown, a researcher in the Biodesign Institutes Center for Environmental Biotechnology and assistant professor in the Ira A. Fulton School of Engineerings Department of Civil and Environmental Engineering.

Transforming the chlorinated solvent to a harmless product is the best way to eliminate the harmful effects of TCE. In the case of TCE, Mother Nature is the best helper. Scientists have discovered specialized microorganisms that can replace the chlorine in the chlorinated molecules with hydrogen, a process called reductive dechlorination
'/>"/>

Contact: Joe Caspermeyer
joseph.caspermeyer@asu.edu
480-727-0369
Arizona State University
Source:Eurekalert  

Page: 1 2 3

Related medicine news :

1. Emmy(R)- and Golden Globe(R)-Nominated Actress Marcia Cross and Lifetime Television Deliver 20 Million Online Petition Signatures to Capitol Hill to Urge Congress to Stop Drive-Through Mastectomies
2. Using HR Performance Metrics to Optimize Operations and Profits
3. Alimera Sciences Signs Second Agreement With Emory University for Potential Treatments Using New Class of Antioxidants
4. AHF Sues L.A. Housing Dept. to Prevent Closure of AIDS Site
5. Upscale Yet Affordable Housing Sets New Standard for Seniors
6. Fox Hill Senior Condominium Development Thrives During National Housing Slump
7. Scientists using laser light to detect potential diseases via breath samples, says new study
8. Using HEPA filters may improve cardiovascular health
9. FTCR: Gov. Schwarzenegger Must Follow Through on Call to Ban Blue Cross From Using Doctors as Double-Agents to Dump Sick Patients
10. 1st EMEA application filed for product using innovative intradermal microinjection system BD Soluvia
11. Vanderbilt University Medical Center and Waters Collaborate on Tissue Imaging Research Using SYNAPT HDMS
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Nature's helpers: Using microorganisms to remove TCE from water
Nature's helpers: Using microorganisms to remove TCE from water
Breaking Medicine Technology:China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 2China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 3China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 5China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 6China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 7China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 8OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 2OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 3OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 4Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation 2Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation 3Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation 4CSHL led team discovers rare mutation dramatically increasing schizophrenia risk 10513 1CSHL led team discovers rare mutation dramatically increasing schizophrenia risk 10513 2LAs BEST Teams Up With American Chemistry Council to Educate Kids About the Benefits of a Healthy Lifestyle and a Healthy Environment 60037 1LAs BEST Teams Up With American Chemistry Council to Educate Kids About the Benefits of a Healthy Lifestyle and a Healthy Environment 60037 2LAs BEST Teams Up With American Chemistry Council to Educate Kids About the Benefits of a Healthy Lifestyle and a Healthy Environment 60037 3Brisk Walk Can Help Leave Common Cold Behind 60034 1Brisk Walk Can Help Leave Common Cold Behind 60034 2